Summary
This 8-K filing from Biogen Idec Inc. (BIIB) on December 21, 2007, primarily concerns the departure of a key executive and the subsequent consulting agreement. Dr. Burt A. Adelman, Executive Vice President of Portfolio Strategy, retired from his executive role effective December 31, 2007. This transition is accompanied by a post-retirement consulting agreement. Investors should note the terms of the consulting agreement, which spans six months following Dr. Adelman's retirement. Biogen Idec will pay Dr. Adelman $400,000 for his continued advisory services during this period. While the filing does not detail the specific nature of the consulting, it suggests a planned and managed transition, allowing the company to retain valuable expertise from a retiring senior leader.
Key Highlights
- 1Dr. Burt A. Adelman, EVP of Portfolio Strategy, retired effective December 31, 2007.
- 2A post-retirement consulting agreement was entered into with Dr. Adelman.
- 3The consulting agreement is for a six-month period, commencing December 31, 2007.
- 4Biogen Idec will pay Dr. Adelman $400,000 for his consulting services.
- 5The agreement allows Biogen Idec to retain Dr. Adelman's expertise during the transition.
- 6The filing details a material definitive agreement regarding executive transition.
- 7No other significant financial or operational events are disclosed in this specific filing.